1. Technology overview
PathPresenter Corporation, based in Montville, New Jersey, was founded in 2017 by dermatopathologist Dr. Rajendra Singh. It offers an enterprise-grade digital pathology image management system built by pathologists, with a vendor-agnostic approach to scanners, formats, LIS and AI models.
The platform includes a Clinical Care viewer for primary diagnosis, ConsultConnect for remote second opinions, education and biobanking or research modules, and a free public edition. A proprietary HL7 middleware links LIS records to slides, and multiple AI vendors can be opened from inside the viewer.
2. Highlighted features & specifications
- Clinical Care: high-volume viewer for primary diagnosis with macros and voice dictation integration.
- ConsultConnect: zero-footprint remote second opinions.
- LIS integration: EPIC, Oracle Cerner and LigoLab via HL7 middleware.
- AI hub: several AI vendors accessed within one viewer.
- Education and research: modules for teaching and biobanking.
- PathPresenter Public: free platform for pathology education.
3. Potential application
A central cancer hospital can receive second-opinion cases from provincial hospitals as digital slides. A medical university can teach pathology with a shared image library. A pharma-linked lab can run AI models on biobank slides.
4. Benefits
Vendor-agnostic design accepts .svs, .ndpi, .tiff and DICOM from different scanners. Remote second opinions avoid shipping glass slides across institutions and countries. FDA 510(k) and CE-IVDR clearance apply to a specified scanner and display configuration. A free public edition supports pathology education.
5. Market trends & opportunities
Hospitals are moving to vendor-neutral image management that connects scanners, LIS and AI. Vietnam's central hospitals can use remote consultation to link provincial pathology labs with specialist centers, which reduces slide shipping time.
6. Other information
Founded 2017 by Dr. Rajendra Singh; HQ at 19 Louis Dr, Montville, NJ. Seed round 2021 and 7.5 million USD Series A in 2024 led by AVANT BIO with Barco NV and Modi Ventures. Partner of the College of American Pathologists for CAP AI Studio. Regulatory clearance applies only to a specific Hamamatsu scanner and Barco display setup.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE









































